The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
1 Year | 5 Year | 5 Year Annualized | Since IPO | |
---|---|---|---|---|
OMI | -63.17% | -79.14% | -26.91% | +103% |
S&P | +15.06% | +95.03% | +14.29% | +3,880% |
Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.
The healthcare logistics company released preliminary third-quarter numbers that investors didn't like.
Q2 2025 | YOY Change | |
---|---|---|
Revenue | $681.92M | -74.5% |
Gross Profit | $297.09M | -38.1% |
Gross Margin | 43.57% | 25.6% |
Market Cap | $697.19M | -32.5% |
Market Cap / Employee | $0.03M | 0.0% |
Employees | 23.2K | 4.5% |
Net Income | -$83.82M | -162.7% |
EBITDA | $108.67M | -15.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
Q2 2025 | YOY Change | |
---|---|---|
Net Cash | $38.26M | -85.1% |
Accounts Receivable | $196.38M | -70.4% |
Inventory | 69.2 | -94.4% |
Q2 2025 | YOY Change | |
---|---|---|
Long Term Debt | $1.68B | -22.8% |
Short Term Debt | $426.70M | 97.2% |
Q2 2025 | YOY Change | |
---|---|---|
Return On Assets | -8.83% | -8.0% |
Return On Invested Capital | 0.26% | -2.5% |
Q2 2025 | YOY Change | |
---|---|---|
Free Cash Flow | -$30.27M | -142.2% |
Operating Free Cash Flow | $37.61M | -67.6% |
Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
---|---|---|---|---|---|
Price to Book | 1.40 | 1.15 | 1.23 | 1.23 | 6.71% |
Price to Sales | 0.11 | 0.09 | 0.07 | 0.08 | -18.47% |
Price to Tangible Book Value | -1.10 | -0.93 | -0.63 | -0.67 | -29.50% |
Price to Free Cash Flow TTM | 2.73 | 6.25 | 7.20 | 315.31 | - |
Enterprise Value to EBITDA | 22.63 | 23.03 | 26.14 | 25.44 | 3.77% |
Free Cash Flow Yield | 36.7% | 16.0% | 13.9% | 0.3% | - |
Return on Equity | -5.5% | -48.7% | -49.9% | -144.1% | 2882.82% |
Total Debt | $2.17B | $2.23B | $2.27B | $2.10B | -11.88% |
OMI earnings call for the period ending September 30, 2021.
OMI earnings call for the period ending June 30, 2021.
OMI earnings call for the period ending March 31, 2021.
OMI earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.